(Q84358949)
Statements
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia (English)
Francisco Javier Peñalver
Alberto Alvarez-Larrán
Laura Gallur
Isidro Jarque
Dolores Caballero
Joaquín Díaz-Mediavilla
Rosalía Bustelos
José Rafael Cabrera
Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA